Irritable bowel syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
 
(38 intermediate revisions by 4 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Irritable Bowel syndrome (IBS) was first mentioned in the Rocky Mountain Medical Journal in 1950. [[Irritable bowel syndrome|IBS]] was described as a [[Psychosomatic illness|psychosomatic]] disorder, not explained by any [[Biochemistry|biochemical]] or [[Structural biology|structural]] abnormalities. Apley and Nash conducted a famous study on 1000 children in Bristol, United Kingdom and were the first to describe recurrent [[abdominal]] [[pain]] (RAP) as the predominant feature of [[Irritable bowel syndrome|IBS]]. In 1978, the first [[Diagnostic|diagnostic criteria]] i.e. the [[Manning criteria|Manning]] [[Criterion|criteria]] was described. It did not specify any required duration for the [[symptoms]] of [[Irritable bowel syndrome|IBS]]. The subsequent [[Criterion|criteria]] saw a reduction in the required duration of [[Symptom|symptoms]] to facilitate early [[diagnosis]] and [[Treatment Planning|treatment]]. In Rome in 1995, an international group of [[Gastroenterologist|gastroenterologists]] defined the [[Diagnosis|diagnostic criteria]] for IBS and this was published in 1999 under the title of the Rome II [[Criterion|criteria]]. This [[Criterion|criteria]] underwent modification and was described as the Rome III [[Criterion|criteria]]. Since June 2016, the [[Criterion|criteria]] being followed is the Rome IV [[Criterion|criteria]].


==Historical Perspective==
==Historical Perspective==


===Discovery===
===Discovery===
{| class="wikitable"
* In 1950, the concept of irritable bowel syndrome ([[Irritable bowel syndrome|IBS]]) was mentioned for the first time without the recognition of any particular [[etiology]], in the ''Rocky Mountain Medical Journal.''
!
*  IBS was described as a [[Psychosomatic illness|psychosomatic]] disorder, not explained by any [[Biochemistry|biochemical]] or [[Structural biology|structural]] abnormalities. <ref name="pmid15418074">{{cite journal |vauthors=BROWN PW |title=The irritable bowel syndrome |journal=Rocky Mt Med J |volume=47 |issue=5 |pages=343–6 |year=1950 |pmid=15418074 |doi= |url=}}</ref>
!
* In 1958, Apley and Nash conducted a study on 1000 children in Bristol, United Kingdom and were the first to describe Recurrent [[Abdominal pain|Abdominal Pain]] (RAP), as the predominant feature of [[Irritable bowel syndrome|IBS]].
|-
* Recurrent [[abdominal pain]] was defined as [[Abdominal pain|pain in the abdomen]] occurring over a duration of at least 3 months, with the severity enough to cause significant impairment of [[Function (biology)|function]].<ref name="pmid13534750">{{cite journal |vauthors=APLEY J, NAISH N |title=Recurrent abdominal pains: a field survey of 1,000 school children |journal=Arch. Dis. Child. |volume=33 |issue=168 |pages=165–70 |year=1958 |pmid=13534750 |pmc=2012205 |doi= |url=}}</ref><ref name="pmid15290263">{{cite journal |vauthors=El-Matary W, Spray C, Sandhu B |title=Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children |journal=Eur. J. Pediatr. |volume=163 |issue=10 |pages=584–8 |year=2004 |pmid=15290263 |doi=10.1007/s00431-004-1503-0 |url=}}</ref>
|
==Landmark Events==
|
* In 1978, the first diagnostic criteria i.e. the [[Manning criteria]] was described. It did not specify any required duration for the [[symptoms]] of [[Irritable bowel syndrome|IBS]].
|-
* In 1984, the ''Kruris'' criteria for IBS specified a duration of at least two years of [[Symptom|symptoms]] necessary for diagnosis.
|
* In 1990, the ''Rome'' criteria reduced [[symptom]] duration to a period of three months to facilitate early [[diagnosis]] and [[Intervention (counseling)|intervention]].
|
* In 1995, an international group of [[Gastroenterologist|gastroenterologists]] met in Rome and defined the [[Diagnosis|diagnostic criteria]] for [[Irritable bowel syndrome|IBS]]. [[Irritable bowel syndrome|IBS]] was not recognized in children prior to 1995 and affected children were diagnosed with recurrent [[abdominal pain]] (RAP) instead.  
|-
* In 1999, the [[Diagnosis|diagnostic criteria]] for IBS was published under the title of the ''Rome II'' [[Criterion|criteria]].  
|
* In 2006, the [[Diagnosis|diagnostic criteria]] for IBS underwent modification with the reduction of [[symptom]] duration from three to two months in [[Pediatrics|pediatric]] patients to allow for early intervention (''Rome  Ⅲ''). Unlike the [[Manning criteria]], incomplete sense of [[Defecation|evacuation]] is not included under the Rome III criteria.<ref name="pmid16678566">{{cite journal |vauthors=Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS |title=Childhood functional gastrointestinal disorders: child/adolescent |journal=Gastroenterology |volume=130 |issue=5 |pages=1527–37 |year=2006 |pmid=16678566 |doi=10.1053/j.gastro.2005.08.063 |url=}}</ref><ref name="pmid29072609">{{cite journal |vauthors=Lacy BE, Patel NK |title=Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome |journal=J Clin Med |volume=6 |issue=11 |pages= |year=2017 |pmid=29072609 |doi=10.3390/jcm6110099 |url=}}</ref><ref name="pmid28875974">{{cite journal |vauthors=Iwańczak B, Iwańczak F |title=[Functional gastrointestinal disorders in children and adolescents. The Rome IV criteria] |language=Polish |journal=Pol. Merkur. Lekarski |volume=43 |issue=254 |pages=75–82 |year=2017 |pmid=28875974 |doi= |url=}}</ref><ref name="pmid28643273">{{cite journal |vauthors=Ghoshal UC |title=Chronic constipation in Rome IV era: The Indian perspective |journal=Indian J Gastroenterol |volume=36 |issue=3 |pages=163–173 |year=2017 |pmid=28643273 |doi=10.1007/s12664-017-0757-1 |url=}}</ref><ref name="pmid28672432">{{cite journal |vauthors=Ghoshal UC |title=Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros |journal=J Neurogastroenterol Motil |volume=23 |issue=3 |pages=334–340 |year=2017 |pmid=28672432 |pmc=5503282 |doi=10.5056/jnm17020 |url=}}</ref><ref name="pmid27477090">{{cite journal |vauthors=Saps M, van Tilburg MA, Lavigne JV, Miranda A, Benninga MA, Taminiau JA, Di Lorenzo C |title=Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials |journal=Neurogastroenterol. Motil. |volume=28 |issue=11 |pages=1619–1631 |year=2016 |pmid=27477090 |doi=10.1111/nmo.12896 |url=}}</ref><ref name="pmid22632582">{{cite journal |vauthors=Dang J, Ardila-Hani A, Amichai MM, Chua K, Pimentel M |title=Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III |journal=Neurogastroenterol. Motil. |volume=24 |issue=9 |pages=853–e397 |year=2012 |pmid=22632582 |doi=10.1111/j.1365-2982.2012.01943.x |url=}}</ref><ref name="pmid14502111">{{cite journal |vauthors=Olden KW |title=The challenge of diagnosing irritable bowel syndrome |journal=Rev Gastroenterol Disord |volume=3 Suppl 3 |issue= |pages=S3–11 |year=2003 |pmid=14502111 |doi= |url=}}</ref>
|
|}
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
 
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
 
==Outbreaks==
*There have been several outbreaks of [disease name], which are summarized below:
 
==Landmark Events in the Development of Treatment Strategies==
*In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
 
==Impact on Cultural History==
 


==Famous Cases==
==Famous Cases==
*The following are a few famous cases of [[disease name]]:
*The following are a few famous cases of [[Irritable bowel syndrome|IBS]]:
**Adolf Hitler
**John F Kennedy
**Kurt Cobain
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 22:07, 1 December 2017

Irritable bowel syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Irritable bowel syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Monitoring

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Irritable bowel syndrome historical perspective On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Irritable bowel syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Irritable bowel syndrome historical perspective

CDC on Irritable bowel syndrome historical perspective

Irritable bowel syndrome historical perspective in the news

Blogs on Irritable bowel syndrome historical perspective

Directions to Hospitals Treating Irritable bowel syndrome

Risk calculators and risk factors for Irritable bowel syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Overview

Irritable Bowel syndrome (IBS) was first mentioned in the Rocky Mountain Medical Journal in 1950. IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. Apley and Nash conducted a famous study on 1000 children in Bristol, United Kingdom and were the first to describe recurrent abdominal pain (RAP) as the predominant feature of IBS. In 1978, the first diagnostic criteria i.e. the Manning criteria was described. It did not specify any required duration for the symptoms of IBS. The subsequent criteria saw a reduction in the required duration of symptoms to facilitate early diagnosis and treatment. In Rome in 1995, an international group of gastroenterologists defined the diagnostic criteria for IBS and this was published in 1999 under the title of the Rome II criteria. This criteria underwent modification and was described as the Rome III criteria. Since June 2016, the criteria being followed is the Rome IV criteria.

Historical Perspective

Discovery

  • In 1950, the concept of irritable bowel syndrome (IBS) was mentioned for the first time without the recognition of any particular etiology, in the Rocky Mountain Medical Journal.
  •  IBS was described as a psychosomatic disorder, not explained by any biochemical or structural abnormalities. [1]
  • In 1958, Apley and Nash conducted a study on 1000 children in Bristol, United Kingdom and were the first to describe Recurrent Abdominal Pain (RAP), as the predominant feature of IBS.
  • Recurrent abdominal pain was defined as pain in the abdomen occurring over a duration of at least 3 months, with the severity enough to cause significant impairment of function.[2][3]

Landmark Events

Famous Cases

  • The following are a few famous cases of IBS:
    • Adolf Hitler
    • John F Kennedy
    • Kurt Cobain

References

  1. BROWN PW (1950). "The irritable bowel syndrome". Rocky Mt Med J. 47 (5): 343–6. PMID 15418074.
  2. APLEY J, NAISH N (1958). "Recurrent abdominal pains: a field survey of 1,000 school children". Arch. Dis. Child. 33 (168): 165–70. PMC 2012205. PMID 13534750.
  3. El-Matary W, Spray C, Sandhu B (2004). "Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children". Eur. J. Pediatr. 163 (10): 584–8. doi:10.1007/s00431-004-1503-0. PMID 15290263.
  4. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS (2006). "Childhood functional gastrointestinal disorders: child/adolescent". Gastroenterology. 130 (5): 1527–37. doi:10.1053/j.gastro.2005.08.063. PMID 16678566.
  5. Lacy BE, Patel NK (2017). "Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome". J Clin Med. 6 (11). doi:10.3390/jcm6110099. PMID 29072609.
  6. Iwańczak B, Iwańczak F (2017). "[Functional gastrointestinal disorders in children and adolescents. The Rome IV criteria]". Pol. Merkur. Lekarski (in Polish). 43 (254): 75–82. PMID 28875974.
  7. Ghoshal UC (2017). "Chronic constipation in Rome IV era: The Indian perspective". Indian J Gastroenterol. 36 (3): 163–173. doi:10.1007/s12664-017-0757-1. PMID 28643273.
  8. Ghoshal UC (2017). "Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros". J Neurogastroenterol Motil. 23 (3): 334–340. doi:10.5056/jnm17020. PMC 5503282. PMID 28672432.
  9. Saps M, van Tilburg MA, Lavigne JV, Miranda A, Benninga MA, Taminiau JA, Di Lorenzo C (2016). "Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials". Neurogastroenterol. Motil. 28 (11): 1619–1631. doi:10.1111/nmo.12896. PMID 27477090.
  10. Dang J, Ardila-Hani A, Amichai MM, Chua K, Pimentel M (2012). "Systematic review of diagnostic criteria for IBS demonstrates poor validity and utilization of Rome III". Neurogastroenterol. Motil. 24 (9): 853–e397. doi:10.1111/j.1365-2982.2012.01943.x. PMID 22632582.
  11. Olden KW (2003). "The challenge of diagnosing irritable bowel syndrome". Rev Gastroenterol Disord. 3 Suppl 3: S3–11. PMID 14502111.

Template:WH Template:WS